Glass House Brands Reports Record Setting Fourth Quarter 2024 Financial Results
Rhea-AI Summary
Glass House Brands (GLASF) reported strong Q4 2024 financial results with revenue of $53.0 million, up 31% year-over-year, and full-year revenue of $200.9 million, a 25% increase from 2023. The company achieved significant growth across all three business segments.
Q4 highlights include:
- Adjusted EBITDA of $9.0 million, up 139% year-over-year
- Biomass production reached 165,074 pounds, up 60% year-over-year
- Production cost decreased to $110 per pound from $121 last year
- Gross profit margin was 43%
- Cash balance increased to $36.9 million
The company provided 2025 guidance, projecting Q1 revenue between $42-44 million and full-year revenue of $220-230 million. A new $50 million senior secured loan was secured, extending debt maturity to 2030. Phase III expansion is underway, including Greenhouse 2 retrofit, which is expected to increase total annual capacity to over 1 million pounds of biomass.
Positive
- Revenue grew 31% YoY to $53.0 million in Q4 2024
- Adjusted EBITDA increased 139% YoY to $9.0 million in Q4
- Biomass production up 60% YoY to 165,074 pounds
- Production costs decreased 9% YoY to $110 per pound
- Secured new $50M senior credit facility extending debt maturity to 2030
- Operating cash flow improved to $8.2M from $1.4M YoY
Negative
- Gross profit margin declined to 43% from 45% YoY in Q4
- Average selling price decreased to $220 per pound from $272 YoY
- G&A expenses increased 11% YoY to $14.8 million
- Professional fees increased 56% QoQ to $1.4 million
News Market Reaction 1 Alert
On the day this news was published, GHBWF gained 1.05%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
- Full year net revenue was
$200.9 million , a25% increase year-over-year - Fourth quarter revenue was
$53.0 million , up31% year-over-year reflecting over20% growth in all three business segments - Fourth quarter adjusted EBITDA was
$9.0 million , up139% year-over-year - Biomass production was 165,074 pounds in the fourth quarter, up
60% year-over-year - Fourth quarter cost per equivalent dry pound of production was
$110 , down from$121 per pound for the equivalent period last year - Fourth quarter consolidated gross profit margin was
43% , compared to45% in Q4 2023 - Cash and restricted cash balance rose to
$36.9 million on December 31, 2024, compared to$35.1 million on September 30, 2024 - Conference call to be held today March 25, 2025, at 5:00 p.m. ET
LONG BEACH, Calif. and TORONTO, March 25, 2025 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House" or the "Company") (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX: GHBWF), one of the fastest-growing, vertically integrated cannabis companies in the U.S., today reported financial results for the fourth quarter and year ended December 31, 2024.
Fourth Quarter 2024 Highlights
(Unless otherwise stated, all results and dollar references are in U.S. dollars)
- Revenue of
$53.0 million , an increase of31% from$40.4 million in Q4 2023. - Gross Profit was
$22.8 million , compared to$18.0 million in Q4 2023. - Gross Profit Margin was
43% , compared to45% in Q4 2023. - Adjusted EBITDA1 was
$9.0 million , compared to$3.8 million in Q4 2023. - Operating Cash Flow was
$8.2 million , compared to$1.4 million in Q4 2023. - Equivalent Dry Pound Production2 was 165,074 pounds, up
60% year-over-year. - Cost per Equivalent Dry Pound of Production3 was
$110 per pound, a decrease of9% compared to the same period last year. - Cash, Restricted Cash and Cash Equivalents balance was
$36.9 million at year-end versus$35.1 million at the end of Q3 2024.
Management Commentary
“2024 was another year of meaningful development for Glass House Brands positioning the Company for its next wave of expansion in the years ahead,” said Kyle Kazan, Co-Founder, Chairman and CEO of Glass House. “We commenced commercial operation of Greenhouse 5 in January, completing Phase II expansion at our SoCal Farm. Greenhouse 5 had its first full quarter of production and sales in Q2 and since that time, production volumes, quality and yields from this facility have all substantially exceeded our original expectations. In the fourth quarter, we began Phase III expansion, including the retrofit of Greenhouse 2 along with investments in related support facilities. We expect initial revenues from this facility by year-end, with production estimated at 275,000 pounds in its first full year of operation while generating consistently high-quality cannabis flower bringing total annual capacity to more than 1 million pounds of biomass.”
“We exited the year strongly, with fourth quarter results exceeding our initial guidance across most of our key metrics including revenue, gross profit margin, cultivation cost per pound, average selling price, adjusted EBITDA and operating cash flow. Consolidated fourth quarter revenue rose
“Our retail and CPG teams also delivered strong quarterly results, including our best quarter for CPG wholesale revenues since the end of our distribution relationship with Herbl. Retail dispensary revenue grew
“In addition to these initiatives, we have also taken steps to strengthen our balance sheet. Recently, we secured a new
“Looking ahead, in 2025 while we plan for pricing pressure in California to persist in the near-term, we will continue to drive operational efficiencies, execute on our strategic product initiatives and place emphasis on our leading brands to drive further growth throughout our retail, CPG and wholesale businesses. We have a winning strategy and even with our outperformance in 2024, we believe we are well positioned for above market growth this year. At the same time, we have obtained our hemp license for Greenhouse 4 and are actively growing and testing hemp-derived cannabis. It is clear that there is massive demand throughout the country, and we are confident that we could sell everything we grow, that is 2018 Farm Bill compliant. We intend to formalize our plans here by the second quarter of this year. Further, our Phase III investment plans remain unchanged, regardless of our plans for hemp,” Mr. Kazan concluded.
Subsequent Events
- Glass House Brands Announces New
$50 Million Senior Secured Loan - Glass House Brands Named to 2025 OTCQX Best 50 for the Second Year in a Row
Q4 2024 Financial Results Discussion
Revenues for Q4 2024 were
The wholesale biomass business achieved revenue of
Retail and CPG revenue combined increased
Q4 2024 retail revenue was
Wholesale CPG revenues were
Fourth quarter consolidated gross profit was
Average selling price was
General and administrative expenses were
Sales and marketing expenses were
Professional fees were
Depreciation and amortization in Q4 2024 were
Adjusted EBITDA was
Operating cash flow was
As of December 31, 2024, the Company had
Year End 2024 Financial Results Discussion
Revenues for 2024 were
Wholesale biomass revenue was
Retail revenue reached
Wholesale CPG revenues were
Full year consolidated gross profit was a record high
General and administrative expenses were
Our efforts to minimize operating expenses paid off again in 2024, as cash operating expenses, which exclude impairment charges, depreciation and amortization and stock compensation were
Sales and marketing expenses were
Professional fees were
Depreciation and amortization for the full year 2024 was
For the full year, we generated a record high of
Full year 2024 operating cash flow was
2025 Outlook
The Company is providing the following guidance for the first quarter of 2025 based on the strength of fourth quarter and year end results and current trends in 2025. This guidance does not contain any operating impact from the Greenhouse 2 expansion.
Q1 2025 Outlook
We expect Q1 revenue to be between
We anticipate Q1 biomass production of 144,000 pounds to 146,000 pounds, representing
We project that the average selling price for wholesale biomass will be in the range of
We project that Q1 2025 cost of production will be
We expect consolidated gross profit margin to be approximately
We project that adjusted EBITDA will be
Full year 2025 Outlook
We anticipate full year 2025 revenue to be between
We anticipate full year biomass production of 760,000 pounds to 780,000 pounds, representing
We project full year 2025 average selling price for wholesale biomass will be in the range of
We project that 2025 cost of production will be
We expect consolidated gross profit margin to be approximately
We project that adjusted EBITDA will be in the mid
Financial results and analyses will be available on the Company’s website on the ‘Investors’ and ‘News & Events’ drop down menus (www.glasshousebrands.com) and SEDAR+ (www.sedarplus.ca).
Unless otherwise stated, all results are in U.S. dollars.
| Net Income / Loss | |||||||||||
| (in thousands) | FY22 | FY23 | FY24 | ||||||||
| Revenues, Net | $ | 84,874 | $ | 160,836 | $ | 200,898 | |||||
| Cost of Goods Sold | 64,162 | 79,867 | 103,505 | ||||||||
| Gross Profit | 20,712 | 80,969 | 97,393 | ||||||||
| % of Net Revenue | 24 | % | 50 | % | 48 | % | |||||
| Operating Expenses: | |||||||||||
| General and Administrative | 45,575 | 52,914 | 60,126 | ||||||||
| Sales and Marketing | 3,427 | 2,838 | 2,418 | ||||||||
| Professional Fees | 9,951 | 7,304 | 7,768 | ||||||||
| Depreciation and Amortization | 12,301 | 14,627 | 15,044 | ||||||||
| Impairment | 5,851 | 52,815 | 6,300 | ||||||||
| Total Operating Expenses | 77,105 | 130,498 | 91,656 | ||||||||
| Income (Loss) from Operations | (56,393 | ) | (49,529 | ) | 5,737 | ||||||
| Interest Expense | 7,608 | 9,819 | 9,184 | ||||||||
| (Gain) Loss on Change in Fair Value of Contingent Liabilities and Shares Payable | (28,869 | ) | 24,399 | (13,724 | ) | ||||||
| Other (Income) Expense, Net | 2,218 | 4,371 | (942 | ) | |||||||
| Total Other (Income) Expense, Net | (19,043 | ) | 38,589 | (5,482 | ) | ||||||
| Income Taxes | (4,385 | ) | 9,943 | 10,498 | |||||||
| Net Income (Loss) | $ | (32,965 | ) | $ | (98,061 | ) | $ | 721 | |||
| Adjusted EBITDA | |||||||||||
| (in thousands) | FY22 | FY23 | FY24 | ||||||||
| Net Income (Loss) (GAAP) | $ | (32,965 | ) | $ | (98,061 | ) | $ | 721 | |||
| Depreciation and Amortization | 12,301 | 14,627 | 15,044 | ||||||||
| Interest Expense | 7,608 | 9,819 | 9,184 | ||||||||
| Income Tax Expense | (4,385 | ) | 9,943 | 10,498 | |||||||
| EBITDA (Non-GAAP) | (17,441 | ) | (63,672 | ) | 35,447 | ||||||
| Adjustments: | |||||||||||
| Share-Based Compensation | 12,756 | 7,637 | 13,098 | ||||||||
| Stock Appreciation Rights Expense | (35 | ) | 219 | 262 | |||||||
| (Gain) Loss on Equity Method Investments | 2,007 | 2,102 | (14 | ) | |||||||
| Change in Fair Value of Derivative Asset | 30 | 28 | (690 | ) | |||||||
| Impairment Expense for Goodwill | 5,851 | 37,912 | — | ||||||||
| Impairment Expense for Intangible Assets | — | 14,903 | 6,300 | ||||||||
| Change in Fair Value of Contingent Liabilities and Shares Payable | (28,869 | ) | 24,399 | (13,724 | ) | ||||||
| Start Up Costs | 1,180 | — | — | ||||||||
| Non-Operational Related Professional Fees | 2,261 | — | — | ||||||||
| Employee Retention Tax Credit | — | — | (423 | ) | |||||||
| Loan Amendment Fee | — | 1,000 | — | ||||||||
| Adjusted EBITDA (Non-GAAP) | $ | (22,260 | ) | $ | 24,528 | $ | 40,256 | ||||
| Select Cash Flow Information | |||||||||||
| (in thousands) | FY22 | FY23 | FY24 | ||||||||
| Net Income (Loss) | $ | (32,965 | ) | $ | (98,061 | ) | $ | 721 | |||
| Depreciation and Amortization | 12,301 | 14,627 | 15,044 | ||||||||
| Share-Based Compensation | 12,756 | 7,637 | 13,098 | ||||||||
| Impairment Expense for Goodwill and Intangibles | 5,851 | 52,815 | 6,300 | ||||||||
| (Gain) Loss on Change in Fair Value of Contingent Liabilities and Shares Payable | (28,869 | ) | 24,399 | (13,724 | ) | ||||||
| Other | (5,857 | ) | 7,948 | 2,908 | |||||||
| Cash From Net Income (Loss) | (36,783 | ) | 9,365 | 24,347 | |||||||
| Accounts Receivable | (1,579 | ) | (172 | ) | (1,481 | ) | |||||
| Income Taxes Receivable | — | — | (1,929 | ) | |||||||
| Prepaid Expenses and Other Current Assets | (1,566 | ) | 3,883 | (3,902 | ) | ||||||
| Inventory | (674 | ) | 2,361 | (5,412 | ) | ||||||
| Other Assets | (2,285 | ) | 191 | 215 | |||||||
| Accounts Payable and Accrued Liabilities | 473 | 5,985 | 8,413 | ||||||||
| Income Taxes Payable | 1,994 | 278 | (5,471 | ) | |||||||
| Other | (365 | ) | 1,333 | 13,612 | |||||||
| Working Capital Impact | (4,002 | ) | 13,859 | 4,045 | |||||||
| Operating Activities Cash Flow | (40,785 | ) | 23,224 | 28,392 | |||||||
| Purchases of Property and Equipment | (27,766 | ) | (12,309 | ) | (10,294 | ) | |||||
| Other | (1,434 | ) | (405 | ) | — | ||||||
| Investing Activities Cash Flow | (29,200 | ) | (12,714 | ) | (10,294 | ) | |||||
| Proceeds from the Issuance of Preferred Shares and Notes Payable | 41,379 | 15,363 | — | ||||||||
| Payments on Notes Payable, Third Parties and Related Parties | (9,888 | ) | (696 | ) | (7,557 | ) | |||||
| Distributions to Preferred Shareholders | (4,000 | ) | (6,331 | ) | (7,749 | ) | |||||
| Other | 2,571 | (466 | ) | 1,607 | |||||||
| Financing Activities Cash Flow | 30,062 | 7,870 | (13,699 | ) | |||||||
| Net Increase (Decrease) in Cash, Restricted Cash and Cash Equivalents | (39,923 | ) | 18,380 | 4,399 | |||||||
| Cash, Restricted Cash and Cash Equivalents, Beginning of Period | 54,067 | 14,144 | 32,524 | ||||||||
| Cash, Restricted Cash and Cash Equivalents, End of Period | $ | 14,144 | $ | 32,524 | $ | 36,923 | |||||
| Select Balance Sheet Information | ||||||||
| (in thousands) | FY22 | FY23 | FY24 | |||||
| Cash and Restricted Cash | $ | 14,144 | $ | 32,524 | $ | 36,923 | ||
| Accounts Receivable, Net | 4,789 | 3,979 | 5,221 | |||||
| Income Taxes Receivable | — | — | 1,929 | |||||
| Prepaid Expenses and Other Current Assets | 7,755 | 3,873 | 7,775 | |||||
| Inventory | 10,950 | 8,840 | 14,252 | |||||
| Notes Receivable | 1,256 | — | — | |||||
| Total Current Assets | 38,894 | 49,216 | 66,100 | |||||
| Operating and Finance Lease Right-of-Use Assets, Net | 11,134 | 10,860 | 10,736 | |||||
| Long Term Investments | 4,246 | 2,327 | 2,341 | |||||
| Property, Plant and Equipment, Net | 216,431 | 215,686 | 212,252 | |||||
| Intangible Assets, Net and Goodwill | 73,719 | 21,213 | 14,200 | |||||
| Deferred Tax Asset | 1,512 | — | — | |||||
| Other Assets | 4,693 | 4,473 | 4,873 | |||||
| TOTAL ASSETS | $ | 350,629 | $ | 303,775 | $ | 310,502 | ||
| Accounts Payable and Accrued Liabilities | $ | 21,969 | $ | 26,932 | $ | 31,128 | ||
| Income Taxes Payable | 7,601 | 7,879 | 2,408 | |||||
| Contingent Shares and Earnout Liabilities | 14,657 | 34,589 | 20,265 | |||||
| Shares Payable | 8,589 | 8,570 | 2,579 | |||||
| Current Portion of Operating and Finance Lease Liabilities | 1,145 | 1,839 | 2,454 | |||||
| Current Portion of Notes Payable | 40 | 7,550 | 7,644 | |||||
| Total Current Liabilities | 54,001 | 87,359 | 66,478 | |||||
| Operating and Finance Lease Liabilities, Net of Current Portion | 10,073 | 9,224 | 8,548 | |||||
| Other Non-Current Liabilities | 2,802 | 5,443 | 20,869 | |||||
| Notes Payable, Net of Current Portion | 62,619 | 56,513 | 50,552 | |||||
| TOTAL LIABILITIES | 129,495 | 158,539 | 146,447 | |||||
| Preferred Equity Series B, C and D | 56,534 | 78,153 | 86,363 | |||||
| Additional Paid-In Capital, Accumulated Deficit and Non-Controlling Interest | 164,600 | 67,083 | 77,692 | |||||
| TOTAL SHAREHOLDERS' EQUITY | 221,134 | 145,236 | 164,055 | |||||
| TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY | $ | 350,629 | $ | 303,775 | $ | 310,502 | ||
| Net Income / Loss | |||||||||||
| (in thousands) | Q4 2023 | Q3 2024 | Q4 2024 | ||||||||
| Revenues, Net | $ | 40,429 | $ | 63,821 | $ | 53,039 | |||||
| Cost of Goods Sold | 22,417 | 30,379 | 30,288 | ||||||||
| Gross Profit | 18,012 | 33,442 | 22,751 | ||||||||
| % of Net Revenue | 45 | % | 52 | % | 43 | % | |||||
| Operating Expenses: | |||||||||||
| General and Administrative | 13,286 | 14,424 | 14,808 | ||||||||
| Sales and Marketing | 634 | 620 | 639 | ||||||||
| Professional Fees | 1,898 | 891 | 1,354 | ||||||||
| Depreciation and Amortization | 3,545 | 3,731 | 3,874 | ||||||||
| Impairment | 31,817 | 6,300 | — | ||||||||
| Total Operating Expenses | 51,180 | 25,966 | 20,675 | ||||||||
| Income (Loss) from Operations | (33,168 | ) | 7,476 | 2,076 | |||||||
| Interest Expense | 3,033 | 2,255 | 2,130 | ||||||||
| (Gain) Loss on Change in Fair Value of Contingent Liabilities and Shares Payable | 5,913 | 17 | (12,296 | ) | |||||||
| Other (Income) Expense, Net | 219 | (523 | ) | (443 | ) | ||||||
| Total Other (Income) Expense, Net | 9,165 | 1,749 | (10,609 | ) | |||||||
| Income Taxes | (4,218 | ) | 8,935 | 526 | |||||||
| Net Income (Loss) | $ | (38,115 | ) | $ | (3,208 | ) | $ | 12,159 | |||
| Adjusted EBITDA | |||||||||||
| (in thousands) | Q4 2023 | Q3 2024 | Q4 2024 | ||||||||
| Net Income (Loss) (GAAP) | $ | (38,115 | ) | $ | (3,208 | ) | $ | 12,159 | |||
| Depreciation and Amortization | 3,545 | 3,731 | 3,874 | ||||||||
| Interest Expense | 3,033 | 2,255 | 2,130 | ||||||||
| Income Tax Expense | (4,218 | ) | 8,935 | 526 | |||||||
| EBITDA (Non-GAAP) | (35,755 | ) | 11,713 | 18,689 | |||||||
| Adjustments: | |||||||||||
| Share-Based Compensation | 1,909 | 2,947 | 3,258 | ||||||||
| Stock Appreciation Rights Expense | 119 | 25 | (159 | ) | |||||||
| Gain on Equity Method Investments | (35 | ) | (45 | ) | (45 | ) | |||||
| Change in Fair Value of Derivative Asset | (195 | ) | (539 | ) | (6 | ) | |||||
| Impairment Expense for Goodwill | 23,768 | — | — | ||||||||
| Impairment Expense for Intangible Assets | 8,049 | 6,300 | — | ||||||||
| Change in Fair Value of Contingent Liabilities and Shares Payable | 5,913 | 17 | (12,296 | ) | |||||||
| Employee Retention Tax Credit | — | — | (423 | ) | |||||||
| Adjusted EBITDA (Non-GAAP) | $ | 3,773 | $ | 20,418 | $ | 9,018 | |||||
| Select Cash Flow Information | |||||||||||
| (in thousands) | Q4 2023 | Q3 2024 | Q4 2024 | ||||||||
| Net Income (Loss) | $ | (38,115 | ) | $ | (3,208 | ) | $ | 12,159 | |||
| Depreciation and Amortization | 3,545 | 3,731 | 3,874 | ||||||||
| Share-Based Compensation | 1,909 | 2,947 | 3,258 | ||||||||
| Impairment Expense for Goodwill and Intangibles | 31,817 | 6,300 | — | ||||||||
| (Gain) Loss on Change in Fair Value of Contingent Liabilities and Shares Payable | 5,913 | 17 | (12,296 | ) | |||||||
| Other | 2,479 | 296 | 778 | ||||||||
| Cash From Net Income (Loss) | 7,548 | 10,083 | 7,773 | ||||||||
| Accounts Receivable | 687 | (251 | ) | 2,653 | |||||||
| Income Taxes Receivable | — | (1,311 | ) | (618 | ) | ||||||
| Prepaid Expenses and Other Current Assets | 92 | (1,937 | ) | (1,472 | ) | ||||||
| Inventory | 3,122 | (2,265 | ) | 2,516 | |||||||
| Other Assets | 293 | (3 | ) | 42 | |||||||
| Accounts Payable and Accrued Liabilities | 1,902 | (916 | ) | (934 | ) | ||||||
| Income Taxes Payable | (12,812 | ) | (3,320 | ) | (1,984 | ) | |||||
| Other | 608 | 13,095 | 216 | ||||||||
| Working Capital Impact | (6,108 | ) | 3,092 | 419 | |||||||
| Operating Activities Cash Flow | 1,440 | 13,175 | 8,192 | ||||||||
| Purchases of Property and Equipment | (6,075 | ) | (1,417 | ) | (2,560 | ) | |||||
| Other | (183 | ) | — | — | |||||||
| Investing Activities Cash Flow | (6,258 | ) | (1,417 | ) | (2,560 | ) | |||||
| Proceeds from the Issuance of Preferred Shares and Notes Payable | 4,120 | — | — | ||||||||
| Payments on Notes Payable, Third Parties and Related Parties | (658 | ) | (1,888 | ) | (1,891 | ) | |||||
| Distributions to Preferred Shareholders | (1,940 | ) | (1,938 | ) | (1,938 | ) | |||||
| Other | (2,073 | ) | 1,249 | 60 | |||||||
| Financing Activities Cash Flow | (551 | ) | (2,577 | ) | (3,769 | ) | |||||
| Net Increase (Decrease) in Cash, Restricted Cash and Cash Equivalents | (5,369 | ) | 9,181 | 1,863 | |||||||
| Cash, Restricted Cash and Cash Equivalents, Beginning of Period | 37,893 | 25,879 | 35,060 | ||||||||
| Cash, Restricted Cash and Cash Equivalents, End of Period | $ | 32,524 | $ | 35,060 | $ | 36,923 | |||||
| Select Balance Sheet Information | ||||||||
| (in thousands) | Q4 2023 | Q3 2024 | Q4 2024 | |||||
| Cash and Restricted Cash | $ | 32,524 | $ | 35,060 | $ | 36,923 | ||
| Accounts Receivable, Net | 3,979 | 7,892 | 5,221 | |||||
| Income Taxes Receivable | — | 1,311 | 1,929 | |||||
| Prepaid Expenses and Other Current Assets | 3,873 | 6,303 | 7,775 | |||||
| Inventory | 8,840 | 16,768 | 14,252 | |||||
| Total Current Assets | 49,216 | 67,334 | 66,100 | |||||
| Operating and Finance Lease Right-of-Use Assets, Net | 10,860 | 10,591 | 10,736 | |||||
| Long Term Investments | 2,327 | 2,296 | 2,341 | |||||
| Property, Plant and Equipment, Net | 215,686 | 213,218 | 212,252 | |||||
| Intangible Assets, Net and Goodwill | 21,213 | 14,381 | 14,200 | |||||
| Other Assets | 4,473 | 4,909 | 4,873 | |||||
| TOTAL ASSETS | $ | 303,775 | $ | 312,729 | $ | 310,502 | ||
| Accounts Payable and Accrued Liabilities | $ | 26,932 | $ | 32,753 | $ | 31,128 | ||
| Income Taxes Payable | 7,879 | 4,392 | 2,408 | |||||
| Contingent Shares and Earnout Liabilities | 34,589 | 32,165 | 20,265 | |||||
| Shares Payable | 8,570 | 2,975 | 2,579 | |||||
| Current Portion of Operating and Finance Lease Liabilities | 1,839 | 2,383 | 2,454 | |||||
| Current Portion of Notes Payable | 7,550 | 7,553 | 7,644 | |||||
| Total Current Liabilities | 87,359 | 82,221 | 66,478 | |||||
| Operating and Finance Lease Liabilities, Net of Current Portion | 9,224 | 8,386 | 8,548 | |||||
| Other Non-Current Liabilities | 5,443 | 20,191 | 20,869 | |||||
| Notes Payable, Net of Current Portion | 56,513 | 52,200 | 50,552 | |||||
| TOTAL LIABILITIES | 158,539 | 162,998 | 146,447 | |||||
| Preferred Equity Series B, C and D | 78,153 | 83,773 | 86,363 | |||||
| Additional Paid-In Capital, Accumulated Deficit and Non-Controlling Interest | 67,083 | 65,958 | 77,692 | |||||
| TOTAL SHAREHOLDERS' EQUITY | 145,236 | 149,731 | 164,055 | |||||
| TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY | $ | 303,775 | $ | 312,729 | $ | 310,502 | ||
| Notes Payable and Preferred Equity | |||||||||||||
| (in thousands) | Q2 2024 | Q3 2024 | Q4 2024 | Comments | |||||||||
| Notes Payable | |||||||||||||
| Secured Credit Facility | $ | 45,625 | $ | 43,750 | $ | 41,875 | Maturity was 11/30/2026. On 2/28/2025, the Company entered into a Senior Secured Credit Facility for an aggregate principal amount of | ||||||
| Series A | 11,895 | 11,895 | 11,895 | ||||||||||
| Series B | 4,111 | 4,111 | 4,111 | ||||||||||
| Plus Convertible Debt | 16,006 | 16,006 | 16,006 | ||||||||||
| Other | (380 | ) | (3 | ) | 315 | Mostly original issue discount | |||||||
| Notes Payable Total | $ | 61,251 | $ | 59,753 | $ | 58,196 | |||||||
| Preferred Equity | |||||||||||||
| Series B | $ | 60,881 | $ | 62,675 | $ | 65,084 | Currently at | ||||||
| Series C | 5,927 | 6,098 | 6,279 | Currently at | |||||||||
| Series D | 15,000 | 15,000 | 15,000 | Currently at | |||||||||
| Preferred Equity Total | $ | 81,808 | $ | 83,773 | $ | 86,363 | |||||||
| Cash Payments | |||||||||||||
| Debt Amortization | $ | 1,889 | $ | 1,889 | $ | 1,889 | |||||||
| Cash Interest | 1,467 | 1,540 | 1,474 | Currently | |||||||||
| Debt Service | 3,356 | 3,429 | 3,363 | ||||||||||
| Series B | 1,247 | 1,250 | 1,250 | ||||||||||
| Series C | 125 | 125 | 125 | ||||||||||
| Series D | 563 | 563 | 563 | ||||||||||
| Preferred Equity Dividends | 1,935 | 1,938 | 1,938 | ||||||||||
| Total Debt Service and Dividends | $ | 5,291 | $ | 5,367 | $ | 5,301 | |||||||
| Dividend Rates for Series B, C, and D | |||||||||||||
| 22.5 | % | 25.0 | % | 20.0 | % | ||||||||
| Series B | 8/31/2024 | 8/31/2025 | 2/28/2027 | Currently at | |||||||||
| Series C | 12/30/2024 | 12/30/2025 | 6/30/2027 | Currently at | |||||||||
| Series D | 8/24/2028 | Currently at | |||||||||||
| *Dividend in excess of cash dividend is paid out as PIK, outstanding preferred equity balance compounds quarterly. | |||||||||||||
| Equity Table | |||||||||||
| (in thousands, except share price) | Q4 2024 | Q3 2024 | Change | Comments | |||||||
| Total Equity and Exchangeable Shares | 76,906 | 76,271 | 635 | Exercise of RSU's, ISO's, issuance of shares for payment on convertible debentures and issuance of shares for At-the-Market Program | |||||||
| Warrants | |||||||||||
| Series D | 2,980 | 2,980 | — | Exercise price of | |||||||
| Series C | 1,000 | 1,000 | — | Exercise price of | |||||||
| Series B | 9,739 | 9,747 | (8 | ) | Exercise price of | ||||||
| SPAC | 30,665 | 30,665 | — | Exercise price of | |||||||
| Total Warrants | 44,384 | 44,392 | (8 | ) | |||||||
| Stock Options | 529 | 600 | (71 | ) | Exercise Price of | ||||||
| RSUs | 3,334 | 3,463 | (129 | ) | Up to 3-year vesting through 2027 | ||||||
| Total | 3,863 | 4,063 | (200 | ) | |||||||
| Share Price at Quarter End | $ | 5.79 | $ | 9.19 | $ | (3.40 | ) | ||||
| Convertible Debentures | |||||||||||
| Series A | $ | 11,895 | $ | 11,895 | $ | — | |||||
| Series B | 4,111 | 4,111 | — | ||||||||
| Total Convertible Debentures | $ | 16,006 | $ | 16,006 | $ | — | |||||
| Number of Shares if Converted Assuming Share Price at Quarter End | 2,764 | 1,742 | 1,023 | ||||||||
| Revenue | |||||||||||||||||||||||||||||||||||||||||||
| (in thousands) | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | FY 2022 | FY 2023 | FY 2024 | ||||||||||||||||||||||||||||||||
| Retail (B2C) | $ | 9,373 | $ | 10,073 | $ | 10,058 | $ | 9,574 | $ | 9,921 | $ | 10,885 | $ | 11,214 | $ | 11,796 | $ | 26,731 | $ | 39,078 | $ | 43,816 | |||||||||||||||||||||
| Wholesale CPG (B2B) | 3,715 | 3,954 | 4,290 | 4,103 | 4,253 | 3,979 | 4,777 | 4,987 | 16,770 | 16,062 | 17,996 | ||||||||||||||||||||||||||||||||
| Wholesale Biomass (B2B) | 14,467 | 30,638 | 33,839 | 26,752 | 15,926 | 39,074 | 47,830 | 36,256 | 41,373 | 105,696 | 139,086 | ||||||||||||||||||||||||||||||||
| Total | $ | 27,555 | $ | 44,665 | $ | 48,187 | $ | 40,429 | $ | 30,100 | $ | 53,938 | $ | 63,821 | $ | 53,039 | $ | 84,874 | $ | 160,836 | $ | 200,898 | |||||||||||||||||||||
| Sequential % Change | |||||||||||||||||||||||||||||||||||||||||||
| Retail (B2C) | (12)% | 7 | % | — | % | (5)% | 4 | % | 10 | % | 3 | % | 5 | % | |||||||||||||||||||||||||||||
| Wholesale CPG (B2B) | (1)% | 6 | % | 8 | % | (4)% | 4 | % | (6)% | 20 | % | 4 | % | ||||||||||||||||||||||||||||||
| Wholesale Biomass (B2B) | (7)% | 112 | % | 10 | % | (21)% | (40)% | 145 | % | 22 | % | (24)% | |||||||||||||||||||||||||||||||
| Total | (8)% | 62 | % | 8 | % | (16)% | (26)% | 79 | % | 18 | % | (17)% | |||||||||||||||||||||||||||||||
| % Change to Prior Year | |||||||||||||||||||||||||||||||||||||||||||
| Retail (B2C) | 93 | % | 108 | % | 56 | % | (10)% | 6 | % | 8 | % | 11 | % | 23 | % | 23 | % | 46 | % | 12 | % | ||||||||||||||||||||||
| Wholesale CPG (B2B) | 70 | % | — | % | (38)% | 10 | % | 14 | % | 1 | % | 11 | % | 22 | % | (13)% | (4)% | 12 | % | ||||||||||||||||||||||||
| Wholesale Biomass (B2B) | 182 | % | 358 | % | 142 | % | 71 | % | 10 | % | 28 | % | 41 | % | 36 | % | 87 | % | 155 | % | 32 | % | |||||||||||||||||||||
| Total | 126 | % | 188 | % | 77 | % | 35 | % | 9 | % | 21 | % | 32 | % | 31 | % | 34 | % | 89 | % | 25 | % | |||||||||||||||||||||
| Gross Profit | |||||||||||||||||||||||||||||||||||||||||||
| (in thousands) | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | FY 2022 | FY 2023 | FY 2024 | ||||||||||||||||||||||||||||||||
| Retail (B2C) | $ | 5,281 | $ | 5,486 | $ | 5,594 | $ | 5,190 | $ | 5,253 | $ | 5,162 | $ | 4,952 | $ | 5,396 | $ | 11,498 | $ | 21,551 | $ | 20,763 | |||||||||||||||||||||
| Wholesale CPG (B2B) | 1,128 | 239 | 241 | (385 | ) | 1,065 | 886 | 1,398 | 1,168 | 76 | 1,223 | 4,517 | |||||||||||||||||||||||||||||||
| Wholesale Biomass (B2B) | 6,165 | 18,647 | 20,176 | 13,207 | 6,208 | 22,626 | 27,092 | 16,187 | 9,138 | 58,195 | 72,113 | ||||||||||||||||||||||||||||||||
| Total | $ | 12,574 | $ | 24,372 | $ | 26,011 | $ | 18,012 | $ | 12,526 | $ | 28,674 | $ | 33,442 | $ | 22,751 | $ | 20,712 | $ | 80,969 | $ | 97,393 | |||||||||||||||||||||
| % of Revenue | |||||||||||||||||||||||||||||||||||||||||||
| Retail (B2C) | 56 | % | 54 | % | 56 | % | 54 | % | 53 | % | 47 | % | 44 | % | 46 | % | 43 | % | 55 | % | 47 | % | |||||||||||||||||||||
| Wholesale CPG (B2B) | 30 | % | 6 | % | 6 | % | (9)% | 25 | % | 22 | % | 29 | % | 23 | % | — | % | 8 | % | 25 | % | ||||||||||||||||||||||
| Wholesale Biomass (B2B) | 43 | % | 61 | % | 60 | % | 49 | % | 39 | % | 58 | % | 57 | % | 45 | % | 22 | % | 55 | % | 52 | % | |||||||||||||||||||||
| Total | 46 | % | 55 | % | 54 | % | 45 | % | 42 | % | 53 | % | 52 | % | 43 | % | 24 | % | 50 | % | 48 | % | |||||||||||||||||||||
| Wholesale Biomass Production and Cost per Pound | |||||||||||||||||||||||||||||||||||||||||||
| Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | FY 2022 | FY 2023 | FY 2024 | |||||||||||||||||||||||||||||||||
| Equivalent Dry Pounds of Production | 48,099 | 103,336 | 101,825 | 103,462 | 61,392 | 149,717 | 232,295 | 165,074 | 193,723 | 356,722 | 608,478 | ||||||||||||||||||||||||||||||||
| % Change to Prior Year | 188 | % | 282 | % | 36 | % | 37 | % | 28 | % | 45 | % | 128 | % | 60 | % | 100 | % | 84 | % | 71 | % | |||||||||||||||||||||
| Cost per Equivalent Dry Pounds of Production | $ | 196 | $ | 139 | $ | 118 | $ | 121 | $ | 182 | $ | 148 | $ | 103 | $ | 110 | $ | 144 | $ | 136 | $ | 123 | |||||||||||||||||||||
| % Change to Prior Year | (18)% | (12)% | (12)% | (5)% | (7)% | 6 | % | (13)% | (9)% | (24)% | (6)% | (10)% | |||||||||||||||||||||||||||||||
| Ending Operational Canopy (000 sq. ft) | 959 | 959 | 959 | 959 | 959 | 1,525 | 1,525 | 1,525 | 959 | 959 | 1,525 | ||||||||||||||||||||||||||||||||
| Wholesale Biomass Sold and Average Selling Price per Pound | |||||||||||||||||||||||||||||||||||||||||||
| Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | FY 2022 | FY 2023 | FY 2024 | |||||||||||||||||||||||||||||||||
| Equivalent Dry Pounds Sold | 49,923 | 90,174 | 100,661 | 98,199 | 56,432 | 137,866 | 209,175 | 164,660 | 172,392 | 338,957 | 568,133 | ||||||||||||||||||||||||||||||||
| % Change to Prior Year | 179 | % | 354 | % | 47 | % | 49 | % | 13 | % | 53 | % | 108 | % | 68 | % | 149 | % | 97 | % | 68 | % | |||||||||||||||||||||
| Equivalent Dry Pounds Sold Average Selling Price | $ | 290 | $ | 340 | $ | 336 | $ | 272 | $ | 282 | $ | 283 | $ | 229 | $ | 220 | $ | 218 | $ | 312 | $ | 245 | |||||||||||||||||||||
| % Change to Prior Year | 54 | % | 43 | % | 65 | % | 15 | % | (3)% | (17)% | (32)% | (19)% | (6)% | 43 | % | (21)% | |||||||||||||||||||||||||||
Equivalent Dry Pounds Average Selling Price excludes the impact of cultivation tax.
Conference Call
The Company will host a conference call to discuss the results today, March 25, 2025, at 5:00 p.m. Eastern Time.
| Webcast and Replay: | Register Here |
| Dial-In Number: | 1.800.715.9871 |
| Conference ID: | 5311439# |
(replay available for approximately 30 days)
In addition, content related to the earnings call including a transcript and audio recording of the call, as well as the Company’s financial statements and management’s discussion and analysis of financial condition and results of operations for the period (upon completion), will be posted to the Company’s website and can be found here. Content from previous reporting periods is also available.
Non-GAAP Financial Measures
Glass House defines EBITDA as Net Income (Loss) (GAAP) adjusted for interest and financing costs, income taxes, depreciation, and amortization. Adjusted EBITDA is defined as EBITDA excluding share-based compensation, stock appreciation rights expense, loss (gain) on equity method investments, impairment expense for goodwill and intangible assets, change in fair value of derivative liabilities, change in fair value of contingent liabilities and shares payable, certain debt-related fees, acquisition related professional fees, and non-operational start-up costs.
EBITDA and Adjusted EBITDA are presented because management has evaluated the financial results both including and excluding the adjusted items and believe that the supplemental non- GAAP financial measures presented provide additional perspective and insights when analyzing the core operating performance of the business. Such supplemental non-GAAP financial measures are not standardized financial measures under U.S. GAAP used to prepare the Company's financial statements and might not be comparable to similar financial measures disclosed by other companies and, thus, should only be considered in conjunction with the GAAP financial measures presented herein.
The Company has provided a table above that provides a reconciliation of the Company's Net Income (Loss) (GAAP) to Adjusted EBITDA for the three months ended December 31, 2024 compared to the three months ended December 31, 2023 and three months ended September 30, 2024 and Net Income (Loss) (GAAP) to Adjusted EBITDA for the year ended December 31, 2024 compared to the year ended December 31 2023, and the year ended December 31, 2022.
Footnotes and Sources:
- EBITDA and Adjusted EBITDA are non-GAAP financial measures that are not defined by U.S. GAAP and may not be comparable to similar measures presented by other companies. Please see “Non-GAAP Financial Measures” herein for further information and for a reconciliation of such non-GAAP measures to the closest GAAP measure.
- Equivalent Dry Pound Production includes all dry production (flower, smalls and trim) plus equivalent dry weight for wet weight and fresh frozen not converted into dry weight by the Company.
- Cost per Equivalent Dry Pound of Production, is the application of a subset of Costs of Goods Sold for cannabis biomass production (including all expenses from nursery and cultivation to curing and trimming - the point at which product is ready for sales as wholesale cannabis or to be transferred to CPG) applied to the Company's metric of dry production which includes all dry production (flower, smalls and trim) plus equivalent dry weight for wet weight and fresh frozen that is not converted into dry goods by the Company.
About Glass House Brands
Glass House is one of the fastest-growing, vertically integrated cannabis companies in the U.S., with a dedicated focus on the California market and building leading, lasting brands to serve consumers across all segments. From its greenhouse cultivation operations to its manufacturing practices, from brand-building to retailing, the company's efforts are rooted in the respect for people, the environment, and the community that co-founders Kyle Kazan, Chairman and CEO, and Graham Farrar, Board Member and President, instilled at the outset. Whether it be through its portfolio of brands, which includes Glass House Farms, PLUS Products, Allswell and Mama Sue Wellness, or its network of retail dispensaries throughout the state of California, which includes The Farmacy, Natural Healing Center and The Pottery, Glass House is committed to realizing its vision of excellence: outstanding cannabis products, produced sustainably, for the benefit of all. For more information and company updates, visit www.glasshousebrands.com/ and https://ir.glasshousebrands.com/contact/email-alerts/.
Forward Looking Statements
This news release contains certain forward-looking information and forward-looking statements, as defined in applicable securities laws (collectively referred to herein as "forward-looking statements"). Forward-looking statements reflect current expectations or beliefs regarding future events or the Company's future performance or financial results. All statements other than statements of historical fact are forward-looking statements. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "continues", "forecasts", "projects", "predicts", "intends", "anticipates", "targets" or "believes", or variations of, or the negatives of, such words and phrases or state that certain actions, events or results "may", "could", "would", "should", "might" or "will" be taken, occur or be achieved. Forward-looking statements in this news release include, without limitation, the Company’s: ability to further deliver strong operational and financial results; ability to continue growing high quality cannabis at the lowest cost; statement that California, the most competitive cannabis market in the world, is experiencing pricing at levels which the Company would describe as destructive, meaning many cultivators in the state are likely having “going concern” issues; statement that while the Company expects lower prices to continue in the short-term, longer-term management expects Glass House will benefit, as the Company is built to weather market cycles and emerge even stronger; statement that consolidation has always been the Company’s thesis which the company sees as an opportunity to expand market share; statement that the Company commenced commercial operation of Greenhouse 5 in January; statement the Company completed Phase II expansion at its SoCal Farm and Greenhouse 5 had its first full quarter of production and sales in Q2; statement that production volumes, quality and yields from this facility have all substantially exceeded our original expectations; statement that the Company expects to start generating revenue from Greenhouse 2 by the fourth quarter of 2025, with Greenhouse 2 production estimated at 275,000 pounds of cannabis in its first full year of production; statement the Company secured a new
Although the Company believes that the expectations expressed in such statements are based on reasonable assumptions, such statements do not guarantee future performance and actual results or developments may differ materially from those in the statements. There are certain factors that could cause actual results to differ materially from those in the forward-looking information, including financial and operational results not proving to be as expected or on the timelines expected; the Company not completing certain proposed acquisition or financing transactions at all, or on the timelines expected; the Company not achieving the synergies expected; and other risks disclosed in the Company's Annual Information Form and other public filings on SEDAR+ at www.sedarplus.ca. Accordingly, readers should not place undue reliance on forward-looking statements.
For more information on the Company, investors are encouraged to review the Company's public filings on SEDAR+ at www.sedarplus.ca. The forward-looking statements and financial outlooks contained in this news release speak only as of the date of this news release or as of the date or dates specified in such statements. The Company disclaims any intention or obligation to update or revise any forward- looking information, whether as a result of new information, future events or otherwise, other than as required by law.
For further information, please contact:
Glass House Brands Inc.
Jon DeCourcey, Vice President of Investor Relations
T: (781) 724-6869
E: ir@glasshousebrands.com
Investor Relations Contact:
KCSA Strategic Communications
Phil Carlson
T: 212-896-1233
E: GlassHouse@kcsa.com